These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 18314217

  • 1. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
    Rodríguez-Torres M, Govindarajan S, Solá R, Clumeck N, Lissen E, Pessôa M, Buggisch P, Main J, Depamphilis J, Dieterich DT.
    J Hepatol; 2008 May; 48(5):756-64. PubMed ID: 18314217
    [Abstract] [Full Text] [Related]

  • 2. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.
    Antivir Ther; 2008 May; 13(8):1057-65. PubMed ID: 19195331
    [Abstract] [Full Text] [Related]

  • 3. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ.
    J Infect Dis; 2005 Dec 01; 192(11):1943-9. PubMed ID: 16267765
    [Abstract] [Full Text] [Related]

  • 4. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.
    Aliment Pharmacol Ther; 2009 Jul 01; 30(1):61-70. PubMed ID: 19292832
    [Abstract] [Full Text] [Related]

  • 5. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D, Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA).
    Aliment Pharmacol Ther; 2007 Dec 01; 26(11-12):1489-98. PubMed ID: 17903235
    [Abstract] [Full Text] [Related]

  • 6. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U, Arkkila PE, Kärkkäinen P, Färkkilä MA.
    Liver Int; 2009 Feb 01; 29(2):153-8. PubMed ID: 18482270
    [Abstract] [Full Text] [Related]

  • 7. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
    Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S, ANRS HC02 - Ribavic Study team.
    AIDS; 2006 Feb 28; 20(4):525-31. PubMed ID: 16470116
    [Abstract] [Full Text] [Related]

  • 8. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
    Szanto P, Grigorescu M, Dumitru I, Serban A.
    J Gastrointestin Liver Dis; 2006 Jun 28; 15(2):117-24. PubMed ID: 16802005
    [Abstract] [Full Text] [Related]

  • 9. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallée M, Heaton S, Conrad A, Pockros PJ, McHutchison JG.
    J Hepatol; 2004 Mar 28; 40(3):484-90. PubMed ID: 15123364
    [Abstract] [Full Text] [Related]

  • 10. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun 28; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 11. [ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].
    Halfon P, Pénaranda G, Cacoub P.
    Gastroenterol Clin Biol; 2009 Mar 28; 33 Suppl 2():S113-7. PubMed ID: 19375039
    [Abstract] [Full Text] [Related]

  • 12. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
    Ashour E, Samy N, Sayed M, Imam A.
    Clin Lab; 2010 Mar 28; 56(3-4):103-10. PubMed ID: 20476641
    [Abstract] [Full Text] [Related]

  • 13. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS.
    Antivir Ther; 2005 Mar 28; 10(3):405-15. PubMed ID: 15918331
    [Abstract] [Full Text] [Related]

  • 14. [Hepatitis-C infection and hepatic steatosis].
    Bosques-Padilla F.
    Gac Med Mex; 2004 Mar 28; 140 Suppl 2():S73-6. PubMed ID: 15641475
    [Abstract] [Full Text] [Related]

  • 15. [ANRS HC 02 RIBAVIC: impact of steatosis in HIV-HCV co-infection].
    Pol S.
    Gastroenterol Clin Biol; 2009 Mar 28; 33 Suppl 2():S110-2. PubMed ID: 19375038
    [Abstract] [Full Text] [Related]

  • 16. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
    Monto A, Dove LM, Bostrom A, Kakar S, Tien PC, Wright TL.
    Hepatology; 2005 Aug 28; 42(2):310-6. PubMed ID: 16025515
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
    Guaraldi G, Lonardo A, Ballestri S, Zona S, Stentarelli C, Orlando G, Carli F, Carulli L, Roverato A, Loria P.
    Arch Med Res; 2011 Nov 28; 42(8):690-7. PubMed ID: 22227046
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A.
    Am J Gastroenterol; 2008 May 28; 103(5):1136-44. PubMed ID: 18477344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.